.png)
Antifungal Agents Market by Drug Type and Infection Type - Global Industry Analysis & Forecast to 2027
Published On : June 2022 Pages : 171 Category: Pharmaceuticals Report Code : HC064014
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Antifungal Agents Market by Drug Type (Azoles, Echinocandins, Allylamines, Polyenes) Infection Type (Systemic Antifungal Infections, Superficial Antifungal Infections) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The anti-fungal agent is a drug detects and removes fungal pathogens from the body with unimportant harmful reactions to a body. Antifungal operators are likewise called as an antimitotic medication which is utilized for counteracting fungal contamination. Contagious disease in the body is happened because of unclean and unhygienic conditions wherein fungal agent thrive. Antifungal specialists duplicate by spreading spores which in this manner lead to contamination on the skin or when breathed in inhaled-fungal infections.
Drivers and Restraints
Increasing awareness unhygienic condition and skin contamination is the main consideration expected to impel the development of the worldwide antifungal operator's market. What's more, rising interest for an antifungal specialist's so as to treat different diseases, for example, parasitic pneumonia, non-deadly contamination, and mucormycosis is another key factor expected to help the objective market development.
Regional Insights
The North America market represented the highest income share and is expected to dominate the worldwide market over the forecast period.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Pfizer, Inc.
- Gilead Sciences, Inc.
- Bayer Healthcare AG
- Sigma-Aldrich Corporation
- Abbott Laboratories, Inc.
- Basilea Pharmaceutical Ltd
- Astellas Pharma, Inc.
- Agilent Technologies, Inc.
- Kramer Laboratories
- Beckman Coulter, Inc.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Antifungal Agents Market, By Drug Type, Estimates and Forecast, 2017-2027 ($Million)
o Azoles
o Echinocandins
o Allylamines
o Polyenes
· Antifungal Agents Market, By Infection Type, Estimates and Forecast, 2017-2027 ($Million)
o Systemic Antifungal Infections
o Superficial Antifungal Infections
· Antifungal Agents Market, By Key Players
o Pfizer, Inc.
o Gilead Sciences, Inc.
o Bayer Healthcare AG
o Sigma-Aldrich Corporation
o Abbott Laboratories, Inc.
o Basilea Pharmaceutical Ltd
o Astellas Pharma, Inc.
o Agilent Technologies, Inc.
o Kramer Laboratories
o Beckman Coulter, Inc.
· Antifungal Agents Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Antifungal Agents Market, By Country
o U.S. Antifungal Agents Market
o Canada Antifungal Agents Market
o Mexico Antifungal Agents Market
o Europe
§ Europe Antifungal Agents Market, By Country
o Germany Antifungal Agents Market
o UK Antifungal Agents Market
o France Antifungal Agents Market
o Russia Antifungal Agents Market
o Italy Antifungal Agents Market
o Rest of Europe Antifungal Agents Market
o Asia-Pacific
§ Asia-Pacific Antifungal Agents Market, By Country
o China Antifungal Agents Market
o Japan Antifungal Agents Market
o South Korea Antifungal Agents Market
o India Antifungal Agents Market
o Southeast Asia Antifungal Agents Market
o Rest of Asia-Pacific Antifungal Agents Market
o South America
§ South America Antifungal Agents Market
o Brazil Antifungal Agents Market
o Argentina Antifungal Agents Market
o Columbia Antifungal Agents Market
o Rest of South America Antifungal Agents Market
o Middle East and Africa
§ Middle East and Africa Antifungal Agents Market
o Saudi Arabia Antifungal Agents Market
o UAE Antifungal Agents Market
o Egypt Antifungal Agents Market
o Nigeria Antifungal Agents Market
o South Africa Antifungal Agents Market
o Rest of MEA Antifungal Agents Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Antifungal Agents Market, By Drug Type
5.1. Introduction
5.2. Global Antifungal Agents Revenue and Market Share by Drug Type (2017-2027)
5.2.1. Global Antifungal Agents Revenue and Revenue Share by Drug Type (2017-2027)
5.3. Azoles
5.3.1. Global Azoles Revenue and Growth Rate (2017-2027)
5.4. Echinocandins
5.4.1. Global Echinocandins Revenue and Growth Rate (2017-2027)
5.5. Allylamines
5.5.1. Global Allylamines Revenue and Growth Rate (2017-2027)
5.6. Polyenes
5.6.1. Global Polyenes Revenue and Growth Rate (2017-2027)
6. Antifungal Agents Market, By Infection Type
6.1. Introduction
6.2. Global Antifungal Agents Revenue and Market Share by Infection Type (2017-2027)
6.2.1. Global Antifungal Agents Revenue and Revenue Share by Infection Type (2017-2027)
6.3. Systemic Antifungal Infections
6.3.1. Global Systemic Antifungal Infections Revenue and Growth Rate (2017-2027)
6.4. Superficial Antifungal Infections
6.4.1. Global Superficial Antifungal Infections Revenue and Growth Rate (2017-2027)
7. Antifungal Agents Market, By Region
7.1. Introduction
7.2. Global Antifungal Agents Revenue and Market Share by Regions
7.2.1. Global Antifungal Agents Revenue by Regions (2017-2027)
7.3. North America Antifungal Agents by Countries
7.3.1. North America Antifungal Agents Revenue and Growth Rate (2017-2027)
7.3.2. North America Antifungal Agents Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Antifungal Agents by Countries
7.4.1. Europe Antifungal Agents Revenue and Growth Rate (2017-2027)
7.4.2. Europe Antifungal Agents Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Antifungal Agents by Countries
7.5.1. Asia-Pacific Antifungal Agents Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Antifungal Agents Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Antifungal Agents by Countries
7.6.1. South America Antifungal Agents Revenue and Growth Rate (2017-2027)
7.6.2. South America Antifungal Agents Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Antifungal Agents by Countries
7.7.1. Middle East and Africa Antifungal Agents Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Antifungal Agents Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Pfizer, Inc.
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Gilead Sciences, Inc.
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Bayer Healthcare AG
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Sigma-Aldrich Corporation
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Abbott Laboratories, Inc.
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Basilea Pharmaceutical Ltd
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Astellas Pharma, Inc.
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Agilent Technologies, Inc.
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Kramer Laboratories
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. Beckman Coulter, Inc.
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Antifungal Agents Market Forecast (2017-2027)
9.1. Global Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Antifungal Agents Market Forecast by Regions (2017-2027)
9.2.1. North America Antifungal Agents Market Forecast (2017-2027)
9.2.1.1. United States Antifungal Agents Market Forecast (2017-2027)
9.2.1.2. Canada Antifungal Agents Market Forecast (2017-2027)
9.2.1.3. Mexico Antifungal Agents Market Forecast (2017-2027)
9.2.2. Europe Antifungal Agents Market Forecast (2017-2027)
9.2.2.1. Germany Antifungal Agents Market Forecast (2017-2027)
9.2.2.2. France Antifungal Agents Market Forecast (2017-2027)
9.2.2.3. UK Antifungal Agents Market Forecast (2017-2027)
9.2.2.4. Russia Antifungal Agents Market Forecast (2017-2027)
9.2.2.5. Italy Antifungal Agents Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Antifungal Agents Market Forecast (2017-2027)
9.2.3. Asia-Pacific Antifungal Agents Market Forecast (2017-2027)
9.2.3.1. China Antifungal Agents Market Forecast (2017-2027)
9.2.3.2. Japan Antifungal Agents Market Forecast (2017-2027)
9.2.3.3. Korea Antifungal Agents Market Forecast (2017-2027)
9.2.3.4. India Antifungal Agents Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Antifungal Agents Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Antifungal Agents Market Forecast (2017-2027)
9.2.4. South America Antifungal Agents Market Forecast (2017-2027)
9.2.4.1. Brazil Antifungal Agents Market Forecast (2017-2027)
9.2.4.2. Argentina Antifungal Agents Market Forecast (2017-2027)
9.2.4.3. Columbia Antifungal Agents Market Forecast (2017-2027)
9.2.4.4. Rest of South America Antifungal Agents Market Forecast (2017-2027)
9.2.5. Middle East and Africa Antifungal Agents Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Antifungal Agents Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Antifungal Agents Market Forecast (2017-2027)
9.2.5.3. Egypt Antifungal Agents Market Forecast (2017-2027)
9.2.5.4. Nigeria Antifungal Agents Market Forecast (2017-2027)
9.2.5.5. South Africa Antifungal Agents Market Forecast (2017-2027)
9.2.5.6. Turkey Antifungal Agents Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Antifungal Agents Market Forecast (2017-2027)
9.3. Antifungal Agents Market Forecast by Drug Type (2017-2027)
9.3.1. Antifungal Agents Forecast by Drug Type (2017-2027)
9.3.2. Antifungal Agents Market Share Forecast by Drug Type (2017-2027)
9.4. Antifungal Agents Market Forecast by Infection Type (2017-2027)
9.4.1. Antifungal Agents Forecast by Infection Type (2017-2027)
9.4.2. Antifungal Agents Market Share Forecast by Infection Type (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Antifungal Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Antifungal Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Antifungal Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Antifungal Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Antifungal Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Antifungal Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Antifungal Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Antifungal Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Antifungal Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Antifungal Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Antifungal Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Antifungal Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Antifungal Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Antifungal Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Antifungal Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Antifungal Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Antifungal Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Antifungal Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Antifungal Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Antifungal Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Antifungal Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Antifungal Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Antifungal Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Antifungal Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Antifungal Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Antifungal Agents Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Antifungal Agents Revenue and Revenue Share by Drug Type (2017-2018)
Figure Global Azoles Revenue and Growth Rate (2017-2018)
Figure Global Echinocandins Revenue and Growth Rate (2017-2018)
Figure Global Allylamines Revenue and Growth Rate (2017-2018)
Figure Global Polyenes Revenue and Growth Rate (2017-2018)
Table Global Antifungal Agents Revenue and Revenue Share by Infection Type (2017-2018)
Figure Global Systemic Antifungal Infections Revenue and Growth Rate (2017-2018)
Figure Global Superficial Antifungal Infections Revenue and Growth Rate (2017-2018)
Table Global Antifungal Agents Revenue by Regions (2017-2018)
Figure North America Antifungal Agents Growth Rate (2017-2018)
Figure North America Antifungal Agents Revenue and Growth Rate (2017-2018)
Figure North America Antifungal Agents by Countries (2017-2018)
Figure North America Antifungal Agents Revenue (Million USD) by Countries (2017-2018)
Figure United States Antifungal Agents Growth Rate (2017-2018)
Figure United States Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Antifungal Agents Growth Rate (2017-2018)
Figure Canada Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Antifungal Agents Growth Rate (2017-2018)
Figure Mexico Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Antifungal Agents Growth Rate (2017-2018)
Figure Europe Antifungal Agents Revenue and Growth Rate (2017-2018)
Figure Europe Antifungal Agents by Countries (2017-2018)
Figure Europe Antifungal Agents Revenue (Million USD) by Countries (2017-2018)
Figure Germany Antifungal Agents Growth Rate (2017-2018)
Figure Germany Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Antifungal Agents Growth Rate (2017-2018)
Figure France Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Antifungal Agents Growth Rate (2017-2018)
Figure UK Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Antifungal Agents Growth Rate (2017-2018)
Figure Russia Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Antifungal Agents Growth Rate (2017-2018)
Figure Italy Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Antifungal Agents Growth Rate (2017-2018)
Figure Rest of Europe Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Antifungal Agents Growth Rate (2017-2018)
Figure Asia-Pacific Antifungal Agents Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Antifungal Agents by Countries (2017-2018)
Figure Asia-Pacific Antifungal Agents Revenue (Million USD) by Countries (2017-2018)
Figure China Antifungal Agents Growth Rate (2017-2018)
Figure China Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Antifungal Agents Growth Rate (2017-2018)
Figure Japan Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Antifungal Agents Growth Rate (2017-2018)
Figure Korea Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Antifungal Agents Growth Rate (2017-2018)
Figure India Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Antifungal Agents Growth Rate (2017-2018)
Figure Southeast Asia Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Antifungal Agents Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Antifungal Agents Growth Rate (2017-2018)
Figure South America Antifungal Agents Revenue and Growth Rate (2017-2018)
Figure South America Antifungal Agents by Countries (2017-2018)
Figure South America Antifungal Agents Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Antifungal Agents Growth Rate (2017-2018)
Figure Brazil Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Antifungal Agents Growth Rate (2017-2018)
Figure Argentina Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Antifungal Agents Growth Rate (2017-2018)
Figure Columbia Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Antifungal Agents Growth Rate (2017-2018)
Figure Rest of South America Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Antifungal Agents Growth Rate (2017-2018)
Figure Middle East and Africa Antifungal Agents Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Antifungal Agents by Countries (2017-2018)
Figure Middle East and Africa Antifungal Agents Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Antifungal Agents Growth Rate (2017-2018)
Figure Saudi Arabia Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Antifungal Agents Growth Rate (2017-2018)
Figure United Arab Emirates Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Antifungal Agents Growth Rate (2017-2018)
Figure Egypt Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Antifungal Agents Growth Rate (2017-2018)
Figure Nigeria Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Antifungal Agents Growth Rate (2017-2018)
Figure South Africa Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Antifungal Agents Growth Rate (2017-2018)
Figure Turkey Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Antifungal Agents Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Antifungal Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Table Pfizer, Inc. Antifungal Agents Financial Overview
Table Gilead Sciences, Inc. Antifungal Agents Financial Overview
Table Bayer Healthcare AG Antifungal Agents Financial Overview
Table Sigma-Aldrich Corporation Antifungal Agents Financial Overview
Table Abbott Laboratories, Inc. Antifungal Agents Financial Overview
Table Basilea Pharmaceutical Ltd Antifungal Agents Financial Overview
Table Astellas Pharma, Inc. Antifungal Agents Financial Overview
Table Agilent Technologies, Inc. Antifungal Agents Financial Overview
Table Kramer Laboratories Antifungal Agents Financial Overview
Table Beckman Coulter, Inc. Antifungal Agents Financial Overview
Figure Global Antifungal Agents Revenue (Millions USD) and Growth Rate (2018-2025)
Table Antifungal Agents Market Forecast by Regions (2018-2025)
Figure North America Antifungal Agents Market Forecast (2018-2025)
Figure United States Antifungal Agents Market Forecast (2018-2025)
Figure Canada Antifungal Agents Market Forecast (2018-2025)
Figure Mexico Antifungal Agents Market Forecast (2018-2025)
Figure Europe Antifungal Agents Market Forecast (2018-2025)
Figure Germany Antifungal Agents Market Forecast (2018-2025)
Figure France Antifungal Agents Market Forecast (2018-2025)
Figure UK Antifungal Agents Market Forecast (2018-2025)
Figure Russia Antifungal Agents Market Forecast (2018-2025)
Figure Italy Antifungal Agents Market Forecast (2018-2025)
Figure Rest of Europe Antifungal Agents Market Forecast (2018-2025)
Figure Asia-Pacific Antifungal Agents Market Forecast (2018-2025)
Figure China Antifungal Agents Market Forecast (2018-2025)
Figure Japan Antifungal Agents Market Forecast (2018-2025)
Figure Korea Antifungal Agents Market Forecast (2018-2025)
Figure India Antifungal Agents Market Forecast (2018-2025)
Figure Southeast Asia Antifungal Agents Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Antifungal Agents Market Forecast (2018-2025)
Figure South America Antifungal Agents Market Forecast (2018-2025)
Figure Brazil Antifungal Agents Market Forecast (2018-2025)
Figure Argentina Antifungal Agents Market Forecast (2018-2025)
Figure Columbia Antifungal Agents Market Forecast (2018-2025)
Figure Rest of South America Antifungal Agents Market Forecast (2018-2025)
Figure Middle East and Africa Antifungal Agents Market Forecast (2018-2025)
Figure Saudi Arabia Antifungal Agents Market Forecast (2018-2025)
Figure United Arab Emirates Antifungal Agents Market Forecast (2018-2025)
Figure Egypt Antifungal Agents Market Forecast (2018-2025)
Figure Nigeria Antifungal Agents Market Forecast (2018-2025)
Figure South Africa Antifungal Agents Market Forecast (2018-2025)
Figure Turkey Antifungal Agents Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Antifungal Agents Market Forecast (2018-2025)
Figure Global Antifungal Agents Forecast by Drug Type (2018-2025)
Figure Global Antifungal Agents Market Share Forecast by Drug Type (2018-2025)
Figure Global Antifungal Agents Forecast by Drug Type (2018-2025)
Figure Global Antifungal Agents Forecast by Infection Type (2018-2025)
Figure Global Antifungal Agents Market Share Forecast by Infection Type (2018-2025)
Figure Global Antifungal Agents Forecast by Infection Type (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|